The MarketWatch News Department was not involved in the creation of this content. Booster Therapeutics is developing a novel therapeutic approach that aims to combat the accumulation of deviant ...
Booster Therapeutics Awarded Grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to Advance New Class of Proteasome Activator Medicines Towards First-in-Human Phase 1 Study ...
Booster Therapeutics is developing a novel therapeutic approach that aims to combat the accumulation of deviant proteins in cells, which are a major driver of Parkinson’s and other complex diseases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback